Expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anemia patientsDecember 13, 2025
Share Facebook Twitter LinkedIn Pinterest Email The first bellwether trial among lawsuits coordinated in California state courts alleging Johnson & Johnson’s talcum powder products caused ovarian cancer will begin Nov. 3. Source link